Laura & Issac Perlmutter Cancer Center-NYU Ambulatory Care Center(ACC) is a clinical research site located in New York, New York, United States 10016.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
Laura & Issac Perlmutter Cancer Center-NYU Ambulatory Care Center(ACC) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Endometrial Neoplasms.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer.
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Laura & Issac Perlmutter Cancer Center-NYU Ambulatory Care Center(ACC) has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Laura & Issac Perlmutter Cancer Center-NYU Ambulatory Care Center(ACC) has 1 clinical trials on record, with 1 currently active. Their work covers Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Endometrial Neoplasms.
Laura & Issac Perlmutter Cancer Center-NYU Ambulatory Care Center(ACC) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.